Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 0 0.000% |
-2,805,045 (Position Closed) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Larimar Therapeutics, Inc. LRMR |
RA Capital Management, L.P. | 0 0.000% |
-1,334,610 (Position Closed) |
Filing History |
| 2022-11-14 4:43 pm Unchanged |
2022-11-14 | 13G | Olema Pharmaceuticals, Inc. OLMA |
RA Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Otonomy, Inc. OTIC |
RA Capital Management, L.P. | 0 0.000% |
-5,600,000 (Position Closed) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Xilio Therapeutics, Inc. XLO |
RA Capital Management, L.P. | 0 0.000% |
-2,002,217 (Position Closed) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 0 0.000% |
-969,479 (Position Closed) |
Filing History |
| 2022-10-24 4:43 pm Purchase |
2022-10-14 | 13G | IMARA Inc. IMRA |
RA Capital Management, L.P. | 805,206 12.250% |
805,206 (New Position) |
Filing History |
| 2022-10-21 06:03 am Purchase |
2022-10-18 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 9,376,402 19.900% |
1,570,233 (+20.12%) |
Filing History |
| 2022-10-19 4:37 pm Purchase |
2022-10-17 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 6,848,911 14.400% |
1,640,000 (+31.48%) |
Filing History |
| 2022-10-17 5:21 pm Purchase |
2022-10-07 | 13G | Inhibrx Biosciences, Inc. INBX |
RA Capital Management, L.P. | 3,185,831 8.160% |
3,185,831 (New Position) |
Filing History |
| 2022-10-17 4:31 pm Purchase |
2022-10-05 | 13G | Adicet Bio, Inc. ACET |
RA Capital Management, L.P. | 2,364,351 5.500% |
2,364,351 (New Position) |
Filing History |
| 2022-10-14 4:03 pm Sale |
2022-10-14 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 0 0.000% |
-9,040,309 (Position Closed) |
Filing History |
| 2022-10-13 4:30 pm Purchase |
2022-10-03 | 13G | Design Therapeutics, Inc. DSGN |
RA Capital Management, L.P. | 2,971,231 5.320% |
2,971,231 (New Position) |
Filing History |
| 2022-10-04 5:14 pm Unchanged |
2022-09-29 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 829,858 11.010% |
0 (Unchanged) |
Filing History |
| 2022-10-03 4:30 pm Purchase |
2022-09-21 | 13G | Alpine Immune Sciences, Inc. ALPN |
RA Capital Management, L.P. | 4,356,632 9.910% |
4,356,632 (New Position) |
Filing History |
| 2022-09-27 10:40 am Unchanged |
2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA |
RA Capital Management, L.P. | 3,588,081 6.090% |
0 (Unchanged) |
Filing History |
| 2022-09-26 5:29 pm Sale |
2022-09-26 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 0 0.000% |
-9,003,018 (Position Closed) |
Filing History |
| 2022-09-26 4:37 pm Purchase |
2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA |
RA Capital Management, L.P. | 3,588,081 6.090% |
3,588,081 (New Position) |
Filing History |
| 2022-09-26 4:29 pm Purchase |
2022-09-15 | 13G | Third Harmonic Bio, Inc. THRD |
RA Capital Management, L.P. | 3,475,687 8.620% |
3,475,687 (New Position) |
Filing History |
| 2022-09-16 4:29 pm Unchanged |
2022-09-14 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 9,003,018 8.650% |
0 (Unchanged) |
Filing History |